logo
Plus   Neg
Share
Email

Stock Alert: LivePerson Jumps 20% On Outlook Better Than Estimates

Shares of conversational commerce and AI software developer LivePerson, Inc. (LPSN) are surging more than 20% Wednesday morning after the company raised its full-year revenue outlook, better than the Street view.

The stock touched a new high of $59.66 this morning.

The company improved its revenue guidance for the full year to a range of $357.0 million to $361.0 million, from $340.0 million to $355.0 million. Analysts polled by Thomson Reuters expect the company to revenue of $347.31 million for the period.

LivePerson Tuesday reported net loss of $0.06 per share for the second-quarter. The consensus estimate was for $0.07 loss.

Revenue increased 29% year-over-year at $91.6 million, beating the average estimate of analysts for $89.35 million.

"With work from home and social distancing the new normal, the concept of the traditional voice call center has become obsolete. Demand for our platform rose significantly in the second quarter as brands rushed to fill the void with AI-powered messaging," said CEO and Founder, Rob LoCascio.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Amid the growing climate crisis, Walmart said it is raising its ambition to zero emissions by 2040, without the use of carbon offsets, across its global operations. The retail giant, along with the Walmart Foundation, also committed to help protect, manage or restore at least 50 million acres of land and one million square miles of ocean by 2030. The European Commission said Friday that it has signed a deal with Sanofi and GlaxoSmithKline to secure up to 300 million doses of their potential COVID-19 vaccine. Acella Pharmaceuticals recalled certain lots of hypothyroidism medication NP Thyroid in the form of tablets due to super potency, the U.S. Food and Drug Administration said in a statement. The company is recalling one lot of 15mg and one lot of 120mg of NP Thyroid that are packaged in 100 count bottles in strengths of 15 mg, and 120 mg, with expiration dates between October 2020 and November 2020.
RELATED NEWS
Follow RTT